Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Clinical Lung Cancer|October 1, 2011
Fibroblast growth factor signaling in non-small-cell lung cancerThomas J Semrad, Philip C MackClinical Genitourinary Cancer|March 18, 2014
Papillary renal cell carcinoma: current progress and future directionsPrzemyslaw W Twardowski, Philip C Mack, Primo N LaraLeukemia Research|April 28, 2009
GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell linesJamie L McCall, Rebekah A Burich, Philip C MackJournal of Cancer Research and Clinical Oncology|April 24, 2014
Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapiesDanielle C Chinn, William S Holland, Philip C MackExpert Review of Anticancer Therapy|December 21, 2012
Efficacy and toxicity differences in lung cancer populations in the era of clinical trials globalization: the 'common arm' approachPhilip C Mack, David R Gandara, Primo N LaraCurrent Opinion in Oncology|June 18, 2009
Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontierRandeep Sangha, Primo N Lara, Philip C Mack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapiesTianhong Li, Hsing-Jien Kung, Philip C Mack, et al.Expert Opinion on Pharmacotherapy|April 2, 2003
Docetaxel in non-small cell lung cancer: a reviewAngela M Davies, Primo N Lara, Philip C Mack, et al.The Journal of Molecular Diagnostics : JMD|February 22, 2021
KRAS G12C-Mutant Non-Small Cell Lung Cancer: Biology, Developmental Therapeutics, and Molecular TestingRajwanth Veluswamy, Philip C Mack, Jane Houldsworth, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Incorporating bortezomib into the treatment of lung cancerAngela M Davies, Primo N Lara, Philip C Mack, et al.Pageof 13